Xiao Dong Chen
About Xiao Dong Chen
Xiao Dong Chen is a Senior Director of Chemistry, Manufacturing and Controls at Roivant Sciences, where he has worked since 2023. He has extensive experience in the pharmaceutical industry, having held various roles at organizations such as Bristol-Myers Squibb and Tulane University.
Current Role at Roivant Sciences
Xiao Dong Chen serves as the Senior Director of Chemistry, Manufacturing, and Controls (CMC) at Roivant Sciences, a position he has held since 2023. In this role, he oversees the development and maintenance of the CMC budget, manages clinical supply chain activities, and leads cross-functional interfaces with third-party partners. His responsibilities include providing technical CMC expertise for due diligence on assets of interest.
Previous Experience at Bristol-Myers Squibb
Prior to his current role, Xiao Dong Chen worked at Bristol-Myers Squibb for nine years, from 2012 to 2021. He held various positions, including Senior Principal Scientist and Drug Product Development Team Leader. His work involved significant contributions to drug development processes and team leadership within the organization.
Academic Background and Education
Xiao Dong Chen earned his Doctor of Philosophy (Ph.D.) from The Ohio State University. He also holds a Master of Science (M.S.) from Tulane University and a Bachelor's Degree from Chongqing University. His educational background provides a strong foundation for his expertise in chemistry and manufacturing processes.
Research and Advisory Roles
Xiao Dong Chen has held several research and advisory roles throughout his career. He worked as a Research Assistant at Tulane University and as a Research Associate at The Ohio State University. Additionally, he served as a Scientific Advisor to Editors and as a member of the Editorial Advisory Board for the Journal of Pharmaceutical Sciences from 2013 to 2021.
Expertise in Pharmaceutical Development
Xiao Dong Chen has developed expertise in novel dehydration approaches for protein pharmaceuticals, including spray drying and spray freeze drying. His technical skills are complemented by his experience in project management and due diligence, particularly in the context of pharmaceutical asset evaluation.